​

Funding Round

Seed Round - DJS Antibodies

Seed Round - DJS Antibodies

Investment Firm

Overview

DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

Announced Date

Dec 22, 2020

Funding Type

Seed

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sedgwick Claims Management Services

Sedgwick Claims Management Services

No designation

Participant Investors

3

Investor Name
Participant InvestorSedgwick Claims Management Services
Participant InvestorAmgen Ventures
Participant InvestorOxford Science Enterprises

Round Details and Background

DJS Antibodies raised $8039468 on 2020-12-22 in Seed Round

DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 01, 2019
Grant - DJS Antibodies
1-undefined
Feb 25, 2015
Pre Seed Round - DJS Antibodies
1-undefined
Dec 22, 2020
Seed Round - DJS Antibodies
4-8.0M
May 20, 2015
Non Equity Assistance - DJS Antibodies
2-undefined

Recent Activity

There is no recent news or activity for this profile.